Why this Blog?

Shortly after my 12 year old nephew was diagnosed with Diabetes 1, I started this blog for he and his mother. There is so much to learn and so much to know and so many unanswered questions. My hope is that it provides a place for knowledge and healing. To your health nephew!
Love Always-
Hannah

Friday, July 20, 2007

Metabolex Announces Full Enrollment Of Phase 2/3 Study Of MBX-102/JNJ 39659100 In Patients With Type 2 Diabetes (Medical News Today)

Metabolex, Inc., a biotechnology company dedicated to the discovery and development of novel therapeutics for diabetes and related metabolic disorders, announced that it has completed enrollment in the 400-patient Phase 2/3 study of its novel insulin sensitizer, MBX-102/JNJ 39659100, in patients with type 2 diabetes. Metabolex will receive a milestone payment from Ortho-McNeil, Inc. [click link ...

Read More...

[Source: Yahoo! News Search Results for Diabetes]

No comments: